ARDS patients often have systemic inflammatory responses, which may lead to changes in serum albumin levels, as albumin is a negative acute-phase reactant, and its levels are associated with the severity of inflammation, disease prognosis, and mortality. The gene discussed is ALB; the disease is acute respiratory distress syndrome.